Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Glucorex SR 500mg tablets
0601022B0BRAAAS
|
Glucorex | Metformin hydrochloride | Endocrine System | 185 |
|
Bolamyn SR 500mg tablets
0601022B0BIAAAS
|
Bolamyn | Metformin hydrochloride | Endocrine System | 177 |
|
Diagemet XL 500mg tablets
0601022B0BLAAAS
|
Diagemet XL | Metformin hydrochloride | Endocrine System | 147 |
|
Meijumet 500mg modified-release tablets
0601022B0BNAAAS
|
Meijumet | Metformin hydrochloride | Endocrine System | 123 |
|
Metabet SR 500mg tablets (Actavis)
0601022B0BJADAS
|
Metabet | Metformin hydrochloride | Endocrine System | 119 |
|
Metformin 1g oral powder sachets sugar free
0601022B0AAAXAX
|
Metformin hydrochloride | Metformin hydrochloride | Endocrine System | 111 |
|
Meijumet 1000mg modified-release tablets
0601022B0BNACAV
|
Meijumet | Metformin hydrochloride | Endocrine System | 91 |
|
Glucient SR 500mg tablets
0601022B0BKAAAS
|
Glucient SR | Metformin hydrochloride | Endocrine System | 83 |
|
Glucient SR 1000mg tablets
0601022B0BKACAV
|
Glucient SR | Metformin hydrochloride | Endocrine System | 75 |
|
Axpinet 850mg tablets
0601022B0BSABAD
|
Axpinet | Metformin hydrochloride | Endocrine System | 74 |
|
Metformin 500mg/5ml oral liquid
0601022B0AAAIAI
|
Metformin hydrochloride | Metformin hydrochloride | Endocrine System | 40 |
|
Metuxtan SR 500mg tablets
0601022B0BQAAAS
|
Metuxtan SR | Metformin hydrochloride | Endocrine System | 40 |
|
Jesacrin 1000mg modified-release tablets
0601022B0BTABAV
|
Jesacrin | Metformin hydrochloride | Endocrine System | 24 |
|
Metabet SR 1000mg tablets (Actavis)
0601022B0BJACAV
|
Metabet | Metformin hydrochloride | Endocrine System | 23 |
|
Rudimet 1000mg prolonged-release tablets
0601022B0BUABAV
|
Rudimet | Metformin hydrochloride | Endocrine System | 12 |
|
Jesacrin 500mg modified-release tablets
0601022B0BTACAS
|
Jesacrin | Metformin hydrochloride | Endocrine System | 11 |
|
Bolamyn SR 1000mg tablets
0601022B0BIABAV
|
Bolamyn | Metformin hydrochloride | Endocrine System | 10 |
|
Rudimet 500mg prolonged-release tablets
0601022B0BUACAS
|
Rudimet | Metformin hydrochloride | Endocrine System | 10 |
|
Glucophage SR 850mg tablets
0601022B0BBAHBB
|
Glucophage | Metformin hydrochloride | Endocrine System | 6 |
|
Meijumet 750mg modified-release tablets
0601022B0BNABAT
|
Meijumet | Metformin hydrochloride | Endocrine System | 6 |
|
Glucient SR 750mg tablets
0601022B0BKABAT
|
Glucient SR | Metformin hydrochloride | Endocrine System | 5 |
|
Metformin 1g/5ml oral solution
0601022B0AAAMAM
|
Metformin hydrochloride | Metformin hydrochloride | Endocrine System | 4 |
|
Metformin 850mg/5ml oral liquid
0601022B0AAAJAJ
|
Metformin hydrochloride | Metformin hydrochloride | Endocrine System | 3 |
|
Jesacrin 750mg modified-release tablets
0601022B0BTAAAT
|
Jesacrin | Metformin hydrochloride | Endocrine System | 1 |
|
Glucophage 1000mg oral powder sachets
0601022B0BBAGAX
|
Glucophage | Metformin hydrochloride | Endocrine System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.